Our paper on lamin B1 loss in myeloid neoplasms in this issue @CellStemCell! Link & previous Tweetorial below. Accompanied by insightful In Translation article by @eirinipapapetr1 that explores the idea of 5q deletion in cancer as an acquired laminopathy. https://t.co/uoWB1EGkVN
— Sergei Doulatov (@Doulatov_lab) April 7, 2022
The print version of our paper on ring sideroblasts in MDS, with insightful commentary by Mario Cazzola! https://t.co/qPVWsRuoBX
— Sergei Doulatov (@Doulatov_lab) April 5, 2022
Surreal to see my first, first-author paper on the cover of @BloodJournal today (https://t.co/aef0eUM0VW)! Thanks to everyone from the @Doulatov_lab and @bradleybio for all of their support throughout! pic.twitter.com/IKFT38Bjbz
— Courtnee Clough (@CourtneeClough) March 31, 2022
I am thrilled to share our latest work in @CellStemCell which discovers that 5q deletion of lamin B1 in myeloid malignancies drives nuclear anomaly and altered HSC function, led by @andreeareilly. Tweetorial and share link below.https://t.co/clBByZJHNM
— Sergei Doulatov (@Doulatov_lab) March 11, 2022
Excited to share our latest work together with @bradleybio led by @CourtneeClough in @BloodJournal which resolves a mystery in hematology and splicing: what causes ring sideroblasts, erythroid cells with iron buildup in mitochondria, in SF3B1-mutant MDS? https://t.co/b8RQtpwCJ5
— Sergei Doulatov (@Doulatov_lab) December 8, 2021
June 2019: We have a new research scientist in the lab, Stephanie Busch. Stephanie completed her B.S. in Biochemistry at the University of Rochester in 2019. Welcome Stephanie!
Congrats to Courtnee Clough, a grad student extraordinaire @MCBSeattle for winning the @UWISCRM fellows award. It’s a pleasure to have you in the lab Courtnee! pic.twitter.com/4p7VTFlh3X
— Sergei Doulatov (@Doulatov_lab) June 18, 2019
April 2019: Our first paper is published online at Blood! Great work by Jasper, Andreea, and Courtnee, and our collaborators across UW and Fred Hutch.
Great to share the first paper from our lab @UWMedicine @uwgenome @UWISCRM online @BloodJournal: Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes https://t.co/9Ix1qBVQKc 1/3
— Sergei Doulatov (@Doulatov_lab) April 23, 2019
March 2019: Rachel Wellington, graduate student in MCB, joins the lab! Welcome Rachel, and great to be co-mentoring with Brandon Hadland at Fred Hutch.
December 2018: Doulatov lab is awarded a 2019 Scholar Award from the American Society of Hematology. Thank you to ASH for supporting our research on the causes of MDS.
The @NIHDirector’s New Innovator Award is supporting Sergei Doulatov @UWMedicine in his research using advanced gene editing and cell engineering techniques to understand more about the development of blood cells. #NIHHighRisk https://t.co/YB7MLJ8JYE
— NIH Common Fund (@NIH_CommonFund) October 2, 2018
September 2018 update:
Lots of exciting things are happening in the lab. Our first MCB student, Courtnee Clough joins the lab! My Adjunct appointment in the Department of Genome Sciences has been approved, so I can officially mentor graduate students.
We also received an R21 grant from NHLBI to generate transfusable red blood cells from iPSCs, and a Discovery Research Grant from the EvansMDS Foundation to study SF3B1 mutations in MDS. Most importantly, we had our first lab outing at Alki Beach this summer (with Frodo – the official lab pug).
Doulatov lab is awarded 2017 Jaconette L. Tietze Young Scientist Research Award. See the announcement here. Thank you to the Tietze Foundation Trust for their support!
2017-10-17
Drug Discovery for Diamond Blackfan Anemia using Reprogrammed Hematopoietic Progenitors is published in Science Translational Medicine.